U.S. Physical Therapy (NYSE:USPH) Upgraded by Zacks Research to Hold Rating

U.S. Physical Therapy (NYSE:USPH) was upgraded by stock analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday,Zacks.com reports.

Other analysts also recently issued research reports about the company. Citizens Jmp dropped their price target on U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating for the company in a research report on Friday, May 8th. Citigroup reiterated an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Barrington Research decreased their price objective on U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, May 13th. Finally, Jefferies Financial Group raised U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $97.50.

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $64.18 on Wednesday. The company has a market cap of $976.74 million, a PE ratio of 128.35, a price-to-earnings-growth ratio of 1.77 and a beta of 1.21. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.41. The stock has a 50-day moving average price of $70.75 and a 200-day moving average price of $76.91. U.S. Physical Therapy has a 12-month low of $58.19 and a 12-month high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). The business had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The business’s revenue was up 7.9% compared to the same quarter last year. During the same quarter last year, the business posted $0.48 EPS. As a group, equities analysts forecast that U.S. Physical Therapy will post 2.99 earnings per share for the current fiscal year.

Insider Transactions at U.S. Physical Therapy

In related news, COO Graham D. Reeve sold 662 shares of the firm’s stock in a transaction dated Wednesday, March 11th. The stock was sold at an average price of $78.86, for a total transaction of $52,205.32. Following the transaction, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at approximately $2,371,951.08. This trade represents a 2.15% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Richard Binstein sold 3,000 shares of the firm’s stock in a transaction dated Friday, March 6th. The shares were sold at an average price of $81.64, for a total value of $244,920.00. Following the transaction, the executive vice president directly owned 24,867 shares in the company, valued at approximately $2,030,141.88. This represents a 10.77% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 2.40% of the company’s stock.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of large investors have recently bought and sold shares of USPH. Hantz Financial Services Inc. increased its stake in U.S. Physical Therapy by 56.4% in the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock worth $29,000 after purchasing an additional 132 shares during the period. Advisory Services Network LLC purchased a new position in U.S. Physical Therapy in the 3rd quarter worth approximately $39,000. EverSource Wealth Advisors LLC increased its stake in U.S. Physical Therapy by 68.8% in the 3rd quarter. EverSource Wealth Advisors LLC now owns 471 shares of the company’s stock worth $40,000 after purchasing an additional 192 shares during the period. GAMMA Investing LLC increased its stake in U.S. Physical Therapy by 207.1% in the 4th quarter. GAMMA Investing LLC now owns 516 shares of the company’s stock worth $40,000 after purchasing an additional 348 shares during the period. Finally, iSAM Funds UK Ltd purchased a new position in U.S. Physical Therapy in the 3rd quarter worth approximately $52,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.